The American Cancer Society Cancer Action Network (ACS CAN), the American Cancer Society Great Lakes Division and the University of Michigan Rogel Cancer Center (UMCCC) briefed members of Michigan's congressional delegation today in Ann Arbor to encourage sustained federal funding for cancer research.
A research study led by Maha Hussain, MD, associate director of clinical research at the University of Michigan Rogel Cancer Center has found that the survival rate for African American men is now comparable to caucasians when it comes to prostate cancer.
As a key step toward providing patients with treatments based on their own DNA profiles, the University of Michigan and the International Genomics Consortium (IGC) have launched a new joint venture, Paradigm, that will help usher in an age of personalized medicine.
Researchers at the University of Michigan Rogel Cancer Center have found that a cancer gene linked to aggressive spread of the disease promotes breast cancer stem cells. The finding implies a new way to target the behavior of these lethal cells.
A new study lead by University of Michigan Rogel Cancer Center researchers, led by lead author Bradley Zebrack, Ph.D., MSW, MPH; shows significant proportions of adolescents and young adult cancer patients are not getting their care needs met.